Olmedillas Eduardo, Rajamanickam Roshan R, Avalos Ruben Diaz, Ana-Sosa-Batiz Fernanda, Zyla Dawid, Zandonatti Michelle A, Harkins Stephanie S, Shresta Sujan, Hastie Kathryn M, Saphire Erica Ollmann
Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Cell Rep. 2025 Aug 26;44(8):116052. doi: 10.1016/j.celrep.2025.116052. Epub 2025 Jul 22.
The continued emergence of SARS-CoV-2 variants necessitates the development of immunogens that promote broad and durable immunity. The SARS-CoV-2 S2 fusion subunit drives viral entry and has sequence conservation among coronavirus spike proteins. Therefore, S2 could represent an immunogen to boost broadly reactive antibodies. However, when expressed without the S1 domain, metastable S2 irreversibly collapses into the post-fusion six-helix bundle conformation. Beyond well-characterized RBD/NTD shifts, biophysical measurements indicate that spike exhibits reversible "breathing" motions. Using an engineered S2-only antigen that retains the pre-fusion viral surface conformation, we isolated S2-specific antibodies from convalescent and vaccinated individuals. One mAb was used to solve a high-resolution cryo-EM structure of pre-fusion S2. Our structure reveals that, relative to intact spike, engineered S2 adopts a more "open" conformation with stabilizing intermolecular interactions at the trimer base and fusion peptide repositioning. This structure could advance next-generation "booster" immunogens and illuminate potential breathing adjustments of the coronavirus spike.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的持续出现使得开发能够促进广泛且持久免疫力的免疫原成为必要。SARS-CoV-2 S2融合亚基驱动病毒进入,并且在冠状病毒刺突蛋白中具有序列保守性。因此,S2可能代表一种能够增强广泛反应性抗体的免疫原。然而,当在没有S1结构域的情况下表达时,亚稳态的S2会不可逆地折叠成融合后六螺旋束构象。除了已充分表征的受体结合结构域(RBD)/N端结构域(NTD)转变外,生物物理测量表明刺突蛋白呈现可逆的“呼吸”运动。我们使用一种仅保留融合前病毒表面构象的工程化S2抗原,从康复者和接种疫苗的个体中分离出了S2特异性抗体。其中一种单克隆抗体(mAb)被用于解析融合前S2的高分辨率冷冻电镜结构。我们的结构表明,相对于完整的刺突蛋白,工程化S2采用了一种更“开放”的构象,在三聚体基部具有稳定的分子间相互作用,并且融合肽重新定位。这一结构可能推动下一代“加强”免疫原的发展,并阐明冠状病毒刺突蛋白潜在的呼吸调整。